Treatment of Parkinson disease with diet-induced hyperketonemia: A feasibility study

@article{Vanitallie2005TreatmentOP,
  title={Treatment of Parkinson disease with diet-induced hyperketonemia: A feasibility study},
  author={Theodore B. Vanitallie and Cathy A. Nonas and Alessandro Di Rocco and Karyn L. Boyar and K Hyams and Steven B. Heymsfield},
  journal={Neurology},
  year={2005},
  volume={64},
  pages={728 - 730}
}
Ketones may bypass the defect in complex I activity implicated in Parkinson disease (PD). [] Key Result Five of seven volunteers with PD were able to prepare a "hyperketogenic" diet at home and adhere to it for 28 days. Substituting unsaturated for saturated fats appeared to prevent cholesterol increases in four volunteers. Unified Parkinson's Disease Rating Scale scores improved in all five during hyperketonemia, but a placebo effect was not ruled out.

Tables from this paper

The therapeutic potential of ketone bodies in Parkinson’s disease
TLDR
A class of endogenous functional metabolites, ketone bodies, which have properties seemingly suited to rescuing mitochondrial function, have been largely overlooked and are being considered for use in clinical trials.
Characteristics of ketogenic diet and its therapeutic properties in central nervous system disorders
TLDR
This review shows how a ketogenic diet induces ketosis, how it works and how the molecular mechanisms of aketogenic diet may be used in the therapy of central nervous system disorders.
Nutritional Ketosis in Parkinson’s Disease — a Review of Remaining Questions and Insights
TLDR
Research pertaining to ketogenic diet, exogenous ketones, fasting, clinical studies, and theoretical review papers regarding therapeutic mechanisms from direct ketone body signaling and indirect metabolic effects are reviewed to establish with greater certainty that there is a reliable symptomatic benefit.
Role of Ketogenic Diets in Neurodegenerative Diseases (Alzheimer’s Disease and Parkinson’s Disease)
TLDR
The goal of this review was to assess the effectiveness of ketogenic diets on the therapy of neurodegenerative diseases and the application of the ketogenic diet to elderly people, which raises certain concerns.
Ketogenic Diet in Neuromuscular and Neurodegenerative Diseases
An increasing number of data demonstrate the utility of ketogenic diets in a variety of metabolic diseases as obesity, metabolic syndrome, and diabetes. In regard to neurological disorders, ketogenic
Clinical Aspects of the Ketogenic Diet
TLDR
This critical analysis of the ketogenic diet should provide the impetus for further clinical and basic research into the diet's application and mechanisms of action.
Ketogenic Diet and Health
TLDR
A brief review describes a selection of the recent studies of KD as applied to chronic metabolic diseases, and provides an estimate of the quality of the evidence for KD’s effects.
Is the Ketogenic Diet the Cure for Multiple Diseases
TLDR
The concept that many neurological conditions are linked pathophysiologically to energy dysregulation could well provide a common research and experimental therapeutics platform, from which the course of several neurological diseases could be favorably influenced by dietary means.
The Ketogenic Diet as a Treatment Paradigm for Diverse Neurological Disorders
TLDR
The concept that many neurological conditions are linked pathophysiologically to energy dysregulation could well provide a common research and experimental therapeutics platform, from which the course of several neurological diseases could be favorably influenced by dietary means.
Ketogenic diet and fasting diet as Nutritional Approaches in Multiple Sclerosis (NAMS): protocol of a randomized controlled study
TLDR
Whether a KD and a FD are superior to a standard diet (SD) in terms of therapeutic effects and disease progression is investigated in a single-center, randomized, controlled, parallel-group study of multiple sclerosis.
...
...

References

SHOWING 1-10 OF 17 REFERENCES
Body Weight Influences Pharmacokinetics of Levodopa in Parkinson's Disease
TLDR
It is suggested that lighter patients with Parkinson's disease probably receive a greater cumulative dosage of LD per kilogram of body weight during long-term treatment, because in clinical practice, LD is administered without any adjustment of the dose to body weight.
D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease.
TLDR
It is shown that addition of 4 mM d-beta-hydroxybutyrate protected cultured mesencephalic neurons from MPP(+) toxicity and hippocampal neurons from Abeta(1-42) toxicity, suggesting that ketone bodies may play a therapeutic role in these most common forms of human neurodegeneration.
Ketone Bodies, Potential Therapeutic Uses
TLDR
Surprisingly, D‐ β‐hydroxybutyrate (abbreviated “βOHB”) may also provide a more efficient source of energy for brain per unit oxygen, supported by the same phenomenon noted in the isolated working perfused rat heart and in sperm.
Plasma levels of amino acids correlate with motor fluctuations in parkinsonism.
Seven patients with Parkinson's disease who experienced severe motor fluctuations in response to levodopa were studied in detail with relation to the effect of dietary protein on their motor
Differential metabolic effects of saturated versus polyunsaturated fats in ketogenic diets.
TLDR
It is demonstrated that a short-term POLY KD induces a greater level of ketosis and improves S(I), without adversely affecting total and low-density lipoprotein cholesterol, compared with a traditional SAT KD.
A ketogenic diet favorably affects serum biomarkers for cardiovascular disease in normal-weight men.
TLDR
The results suggest that a short-term ketogenic diet does not have a deleterious effect on CVD risk profile and may improve the lipid disorders characteristic of atherogenic dyslipidemia.
Placebo‐associated improvements in motor function: Comparison of subjective and objective sections of the UPDRS in early Parkinson's disease
The Unified Parkinson's Disease Rating Scale (UPDRS) is primarily composed of an investigator‐derived objective rating of motor function and a patient‐derived assessment of activities of daily living
Complex I and Parkinson's Disease
TLDR
Chronic rotenone exposure accurately recapitulated the pathological, biochemical, and behavioral features of PD, suggesting relatively subtle complex I abnormalities‐‐either genetic or acquired‐‐may be central to the pathogenesis of PD.
The ketogenic diet: 1997.
TLDR
The ketogenic diet offers a new paradigm to think about epilepsy and its treatment, and perhaps will stimulate new approaches to this still often devastating condition.
...
...